Dynamics of some biochemical indices in myocardial infarction treated with thrombolysis and creatine phosphate
Language English Country Czech Republic Media print
Document type Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study
PubMed
9431703
Knihovny.cz E-resources
- MeSH
- Fibrinolytic Agents therapeutic use MeSH
- Phosphocreatine therapeutic use MeSH
- Myocardial Infarction drug therapy MeSH
- Middle Aged MeSH
- Humans MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Clinical Trial, Phase II MeSH
- Clinical Trial MeSH
- Multicenter Study MeSH
- Names of Substances
- Fibrinolytic Agents MeSH
- Phosphocreatine MeSH
There was studied the effect of intravenously administered creatin phosphate (Neoton-drug with cardioprotective effect, Alfa Schiapparelli Wassermann) in the group of 98 patients affected by their first attack of myocardial infarction. In the course of the treatment there were observed the serum level of many biochemical indices, including the cardioselective enzyme activity. We concluded that the patients treated with Neoton, compared with the control group, revealed the significantly higher elevation of the CK, AST and LDH activity levels and the shift of the CK peak activity towards to the earlier hours after the onset of anginal pain.
